Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127403221 | 12740322 | 1 | I | 20121031 | 20160907 | 20160913 | 20160913 | EXP | US-AMNEAL PHARMACEUTICALS-2016AMN00516 | AMNEAL | 80.00 | YR | F | Y | 62.59000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127403221 | 12740322 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Y | 75927 | |||||||||||
| 127403221 | 12740322 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Y | 75927 | |||||||||||
| 127403221 | 12740322 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | Y | 0 | ||||||||||
| 127403221 | 12740322 | 4 | C | L-Thyroxin | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 127403221 | 12740322 | 5 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
| 127403221 | 12740322 | 6 | C | PRAVASTATIN. | PRAVASTATIN | 1 | UNK | 0 | |||||||||||
| 127403221 | 12740322 | 7 | C | GLIPIZIDE XL | GLIPIZIDE | 1 | UNK | 0 | |||||||||||
| 127403221 | 12740322 | 8 | C | metformin hcl | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127403221 | 12740322 | 9 | C | COENZYME Q10 | UBIDECARENONE | 1 | UNK | 0 | |||||||||||
| 127403221 | 12740322 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127403221 | 12740322 | 1 | Osteoarthritis |
| 127403221 | 12740322 | 2 | Rheumatoid arthritis |
| 127403221 | 12740322 | 4 | Hypothyroidism |
| 127403221 | 12740322 | 5 | Hypertension |
| 127403221 | 12740322 | 6 | Dyslipidaemia |
| 127403221 | 12740322 | 7 | Type 2 diabetes mellitus |
| 127403221 | 12740322 | 8 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127403221 | 12740322 | OT |
| 127403221 | 12740322 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127403221 | 12740322 | Coronary artery disease | |
| 127403221 | 12740322 | Dizziness | |
| 127403221 | 12740322 | Nausea | |
| 127403221 | 12740322 | Renal artery stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127403221 | 12740322 | 3 | 20110608 | 20121031 | 0 |